Fate Therapeutics (NASDAQ:FATE) Given New $7 00 Price Target at Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fate Therapeutics (NASDAQ:FATE – Get Free Report) will be announcing its earnings results after the market closes on Monday, February 26th. Analysts expect the company to announce earnings of ($0.57) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Fate Therapeutics Trading […]
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) dropped 8.9% during mid-day trading on Tuesday . The company traded as low as $6.79 and last traded at $6.89. Approximately 1,059,618 shares were traded during trading, a decline of 66% from the average daily volume of 3,098,507 shares. The stock had previously closed at […]
Cancer Immunotherapy Stocks – Tapping into Immune Systems for Next Generation Treatments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring Oncolytics Biotech® Inc. , a clinical-stage.